Beijing, China

Zhang J Liang

This inventor holds 1 USPTO granted patent. Top assignee: Taiho Pharmaceutical Company Limited. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhang J Liang. Retrieved from https://idiyas.com/inventor/zhang-j-liang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zhang J Liang: Innovator in Pharmaceutical Chemistry

Introduction

Zhang J Liang is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical chemistry. His work focuses on innovative compounds that have potential applications in medicine.

Latest Patents

Zhang J Liang holds a patent for a compound known as 3-(7'-oxo-1'-aza-4'-oxabicyclo[3.2.0]-hept-3'-YL)propionic acid. This derivative is represented by a specific formula, wherein various groups can be substituted to enhance its properties. The patent highlights the versatility of the compound, which includes various functional groups that can be modified for different applications.

Career Highlights

Zhang J Liang is currently associated with Taiho Pharmaceutical Company Limited. His role at the company allows him to engage in cutting-edge research and development. His expertise in the field has led to advancements in pharmaceutical formulations and drug development.

Collaborations

Zhang has collaborated with notable colleagues such as Tomohiro Yamashita and Toshiyuki Toko. These collaborations have fostered a productive environment for innovation and have contributed to the success of their projects.

Conclusion

Zhang J Liang is a prominent figure in pharmaceutical innovation, with a focus on developing new compounds that can lead to significant advancements in medicine. His contributions and collaborations continue to shape the future of pharmaceutical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…